Peter DeMuth

Technik-/Wissenschafts-/F&E-Leiter bei ELICIO THERAPEUTICS, INC.

Vermögen: - $ am 31.05.2024

38 Jahre

Health Technology

Finance

Consumer Services

Aktive Positionen von Peter DeMuth

Unternehmen	Position	Beginn	Ende
ELICIO THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2022	-

Unternehmen	Position	Beginn	Ende
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2017	01.06.2023

Massachusetts Institute of Technology	Doctorate Degree
University of Maryland	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ELICIO THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology